Full Press Release Details
AC Immune Presents First in Vivo Images of Brain TDP 43 Pathology From Phase 1 Trial of PET Tracer ACI 19626 at AD Pdtm 2026.
ACIU
AC Immune Presents First in Vivo Images of Brain TDP 43 Pathology From Phase 1 Trial of PET Tracer ACI 19626 at AD Pdtm 2026
Key Takeaway: AC Immune Presents First in Vivo Images of Brain TDP 43 Pathology From Phase 1 Trial of PET Tracer ACI 19626 at AD Pdtm 2026